(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-1.37%) $82.70
(6.50%) $2.05
(0.03%) $2 347.80
(-0.29%) $27.46
(4.06%) $959.55
(-0.23%) $0.933
(-0.36%) $10.99
(-0.54%) $0.796
(1.66%) $93.40
-0.42% HKD 4.77
Live Chart Being Loaded With Signals
SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally...
Stats | |
---|---|
Volumen de hoy | 2.42M |
Volumen promedio | 2.05M |
Capitalización de mercado | 14.16B |
EPS | HKD0 ( 2024-03-27 ) |
Last Dividend | HKD0.0700 ( 2023-09-14 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.84 |
ATR14 | HKD0.00700 (0.15%) |
Volumen Correlación
SSY Group Ltd Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
SSY Group Ltd Correlación - Moneda/Commodity
SSY Group Ltd Finanzas
Annual | 2023 |
Ingresos: | HKD6.46B |
Beneficio Bruto: | HKD3.49B (53.99 %) |
EPS: | HKD0.440 |
FY | 2023 |
Ingresos: | HKD6.46B |
Beneficio Bruto: | HKD3.49B (53.99 %) |
EPS: | HKD0.440 |
FY | 2022 |
Ingresos: | HKD6.43B |
Beneficio Bruto: | HKD3.44B (53.46 %) |
EPS: | HKD0.380 |
FY | 2021 |
Ingresos: | HKD5.36B |
Beneficio Bruto: | HKD3.17B (59.18 %) |
EPS: | HKD0.260 |
Financial Reports:
No articles found.
SSY Group Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0600 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.160 (N/A) |
HKD0.0700 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.00500 | 2008-05-23 |
Last Dividend | HKD0.0700 | 2023-09-14 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 32 | -- |
Total Paid Out | HKD1.257 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 4.32 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.77 | |
Div. Directional Score | 10.00 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3326.HK | Ex Dividend Knight | 2023-06-07 | Annually | 0 | 0.00% | |
1553.HK | Ex Dividend Junior | 2023-06-09 | Annually | 0 | 0.00% | |
0595.HK | Ex Dividend Junior | 2023-09-06 | Annually | 0 | 0.00% | |
9616.HK | Ex Dividend Junior | 2023-08-07 | Annually | 0 | 0.00% | |
2119.HK | Ex Dividend Knight | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
1120.HK | Ex Dividend Knight | 2023-06-12 | Annually | 0 | 0.00% | |
0207.HK | Ex Dividend Junior | 2023-06-12 | Sporadic | 0 | 0.00% | |
3818.HK | Ex Dividend Knight | 2023-08-21 | Annually | 0 | 0.00% | |
1709.HK | No Dividend Player | 2023-09-13 | Annually | 0 | 0.00% | |
0737.HK | Ex Dividend Knight | 2023-09-21 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.204 | 1.500 | 5.92 | 8.88 | [0 - 0.5] |
returnOnAssetsTTM | 0.110 | 1.200 | 6.33 | 7.59 | [0 - 0.3] |
returnOnEquityTTM | 0.199 | 1.500 | 8.91 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.338 | -1.000 | 6.62 | -6.62 | [0 - 1] |
currentRatioTTM | 2.03 | 0.800 | 4.84 | 3.87 | [1 - 3] |
quickRatioTTM | 1.587 | 0.800 | 5.37 | 4.30 | [0.8 - 2.5] |
cashRatioTTM | 0.659 | 1.500 | 7.45 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.282 | -1.500 | 5.31 | -7.96 | [0 - 0.6] |
interestCoverageTTM | 11.88 | 1.000 | 6.71 | 6.71 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.325 | 2.00 | 9.89 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0880 | 2.00 | 9.96 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.486 | -1.500 | 8.06 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.540 | 1.000 | 4.34 | 4.34 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.231 | 1.000 | 7.39 | 7.39 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.287 | 1.000 | 9.52 | 9.52 | [0.2 - 2] |
assetTurnoverTTM | 0.540 | 0.800 | 9.73 | 7.79 | [0.5 - 2] |
Total Score | 12.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.78 | 1.000 | 9.01 | 0 | [1 - 100] |
returnOnEquityTTM | 0.199 | 2.50 | 9.30 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0880 | 2.00 | 9.97 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.81 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.325 | 2.00 | 9.89 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.338 | 1.500 | 6.62 | -6.62 | [0 - 1] |
pegRatioTTM | 0.559 | 1.500 | 9.61 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.149 | 1.000 | 8.76 | 0 | [0.1 - 0.5] |
Total Score | 7.77 |
SSY Group Ltd
SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; and food, beverages, and catering business. It sells its products under Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was incorporated in 2004 and is headquartered in Wanchai, Hong Kong. SSY Group Limited is a subsidiary of China Pharmaceutical Co., Ltd.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico